Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

A Review of U.S. ANDA Approvals Received by Chinese Pharmaceutical Enterprises in the First Half of 2019

PharmaSources/CaicaiJuly 16, 2019

Tag: 2019 , apixaban , pharmaceutical , ANDA

PharmaSources Customer Service